Viewing Study NCT05456659


Ignite Creation Date: 2025-12-24 @ 2:43 PM
Ignite Modification Date: 2026-01-10 @ 4:17 PM
Study NCT ID: NCT05456659
Status: UNKNOWN
Last Update Posted: 2022-07-20
First Post: 2022-04-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Renal Replacement Therapy in Neonates
Sponsor: University Hospital, Strasbourg, France
Organization:

Study Overview

Official Title: Renal Replacement Therapy in Neonates : a Retrospective Monocentric Cohort Study
Status: UNKNOWN
Status Verified Date: 2022-04
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Neo-Renal
Brief Summary: The circumstances for setting up dialysis in the neonatal period are multiple: congenital anomaly of the kidney and urinary tract (CAKUT), secondary acute renal failure whose etiologies are multiple (sepsis, hypovolemia, respiratory distress syndrome, neonatal asphyxia, Arterial or venous renal thrombosis, nephrotoxic drugs, etc.), metabolic diseases (mainly hyperammonemia and leucinosis) and post-operative management of heart disease: analysis of the characteristics of the patients in our study and comparison with existing epidemiological data in the literature.

The decision to set up dialysis in a newborn whose recovery of renal function is uncertain or in a context of acute multi-visceral failure is not always obvious and must be discussed carefully. multidisciplinary in connection with neonatologists, resuscitators and nephrologists as well as families with the consideration of the future quality of life of the child.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: